SNAP2

SNAP2 predicts the functional impact of single amino acid substitutions in proteins using a neural network classifier to distinguish effect versus neutral variants for interpretation of genetic variation.

Key Features:

• Neural network-based classification: Employs a neural network architecture that screens an extensive array of protein features and refines development datasets to differentiate effectual and neutral variants.
• Performance metrics: Demonstrated a two-state accuracy of 83% for effect/neutral predictions in cross-validation tests involving over 100,000 experimentally annotated variants and outperformed combinations of other methods.
• Reliability index: Integrates a calibrated reliability index that identifies the top half of predicted effect variants with over 96% accuracy.
• Evolutionary information from MSAs: Leverages evolutionary information derived from automatically generated multiple sequence alignments.
• Alignment-free prediction mode: Provides an alignment-free prediction capability that accelerates runtime by over two orders of magnitude and facilitates cross-genome comparisons and analysis of sequence orphans (≈10–20% of sequences).

Scientific Applications:

• Personalized medicine: Prioritizes protein variants for interpretation of individual genetic variation impacting health.
• Functional genomics: Assists annotation of variant effects across organisms to support genotype–phenotype studies.
• Drug discovery and development: Identifies functionally significant variants that can inform therapeutic target selection and validation.

Methodology:

SNAP2 applies a neural network classifier trained on refined development datasets that screen extensive protein features, leverages evolutionary information from automatically generated multiple sequence alignments, offers an alignment-free prediction mode, and was evaluated by cross-validation on over 100,000 experimentally annotated variants with a calibrated reliability index.